Skip to content

13F-HR filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 20:32:55 UTC, with 47 holding rows worth $538,308,196.

Accession
0001958125-26-000012
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 47 entries on the cover page, a total value of $538,308,196 stated on the cover page (in dollars after the unit check, H1), rows summing to $538,308,196 with VALUE read as dollars as filed, 13F file number 028-25237. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVALYN PHARMA INC05348Y105COMMON STOCK1,698,851$48,400,265dollars as filed
Bristol-Myers Squibb Company110122108COM499,716$31,182,278dollars as filed
BRIDGEBIO PHARMA INC10806X102COM425,111$27,972,304dollars as filed
PARABILIS MEDICINES INC COM698955101Stock824,043$26,608,348dollars as filed
Johnson & Johnson478160104COM99,496$26,340,571dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*101,445$23,112,214dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM315,247$20,632,916dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM1,023,510$19,241,988dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS497,964$18,952,510dollars as filed
CELCUITY INC15102K100COM230,609$18,338,028dollars as filed
SEPTERNA INC COM81734D104Stock454,015$17,765,607dollars as filed
GUARDANT HEALTH INC COM40131M109Stock92,579$16,512,390dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM112,418$15,838,572dollars as filed
10X GENOMICS INC CL A COM88025U109Stock164,029$14,821,660dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM505,882$14,721,166dollars as filed
MINERALYS THERAPEUTICS INC603170101COM583,364$14,659,937dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock161,121$13,907,965dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM1,021,499$11,767,668dollars as filed
VERADERMICS INC922967104COMMON STOCK95,646$11,595,165dollars as filed
ENTERA BIO LTDM40527109SHS3,921,568$11,411,763dollars as filed
DISC MEDICINE INC COM254604101Stock172,709$11,305,531dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK457,839$10,173,183dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock684,753$9,798,815dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM601,760$9,044,453dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM144,971$8,698,260dollars as filed
ANNEXON INC03589W102COM1,986,806$8,404,189dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM85,614$8,151,737dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY260,109$8,133,608dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK126,817$7,678,135dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR211,985$6,421,026dollars as filed
COGENT BIOSCIENCES INC19240Q201COM167,716$5,370,266dollars as filed
KAILERA THERAPEUTICS INC482931102COMMON STOCK468,750$5,353,125dollars as filed
NATERA INC COM632307104Stock12,530$5,178,774dollars as filed
FRACTYL HEALTH INC35168W103COM8,841,707$4,813,425dollars as filed
KARDIGAN INC485925101CMN312,500$4,609,375dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM1,637,114$4,141,898dollars as filed
HEARTFLOW INC42238D107COM74,969$3,729,708dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW699,532$2,868,081dollars as filed
KORSANA BIOSCIENCES INC23255M303COMMON STOCK87,702$2,806,464dollars as filed
FREENOME INC35661P100COMMON STOCK158,170$2,491,178dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK512,287$1,562,475dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK976,191$1,190,953dollars as filed
HYPERFINE INC44916K106Common Stock1,303,155$1,052,949dollars as filed
METAGENOMI THERAPEUTICS INC59102M104COM528,993$560,733dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW14,718$437,713dollars as filed
OUTSET MED INC690145206COM NEW107,456$322,368dollars as filed
ADARx Pharmaceuticals, Inc.00654F105Common Stock, par value $0.0001 per share11,357$226,459dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001958125-26-000012this filing2026-11-16